Lauxera Capital Partners, founded in 2020 with offices in Paris and San Francisco, focuses on health tech, biotech, and deep tech. They invest in Series A and Series E companies, with check sizes from low to high amounts. Notable investments include BioLamina and OrganOx. Managed by experienced healthcare investors and entrepreneurs, Lauxera aims to support European health tech entrepreneurs in turning their ideas into successful businesses.
